Moderated-fat Diet Complemented With Green Tea Reduces oxLDL and Fat Mass in Obese Women
GTRoxLDL
1 other identifier
interventional
64
1 country
1
Brief Summary
Background: Obesity is a chronic degenerative disease, considered as cardiovascular risk factor, characterized by systemic inflammation and high levels of oxLDL. Clinical studies have suggested that drink green tea could improve these complications. Objective: Analyze the effect of a moderate-fat diet complemented with green tea on oxLDL, fat mass and TNFa in obese women. Design: Randomized, controlled clinical trial. Obese women, without other chronic-degenerative disease were divided using a computer-generated random sequence: control group (CON) with n=32, and intervention group (INT) with n=32; and were instructed to consume a moderate-fat diet, and INT group was instructed to complement the diet with green tea. Anthropometric and biochemical measurements were performed, and oxLDL and TNFa s levels were determined by ELISA. All parameters were realized at baseline and in the 1st, 2nd and 3rd months post-intervention. TNFa mRNA expression was determined by real-time RT-PCR (basal and final). The changes on lipid profile, oxLDL, fat mass and TNFalpha expression were reported of the comparison between basal and final time points. The statistical analysis was performed with SPSS software.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Apr 2007
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2007
CompletedFirst Submitted
Initial submission to the registry
May 17, 2012
CompletedFirst Posted
Study publicly available on registry
June 27, 2012
CompletedJuly 20, 2012
July 1, 2012
8 months
May 17, 2012
July 19, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in low density cholesterol
Change in low density cholesterol, change in high density cholesterol, change in triglycerides, change in oxLDL and change in fat mass were assessed at the beginning and at each month during 3 months of intervention. Change in TNF alpha levels was assessed at the beginning and after 3 months. The final changes of all the measures were reported of the comparation between basal and after 3 months.
Change from baseline in lipids, fat mass and TNF aplha levels at 3 months.
Secondary Outcomes (5)
change in high density cholesterol
baseline, 3 months
change in triglycerides
baseline, 3 months
change in oxLDL
baseline, 3 months
change in fat mass
baseline, 3 months
change in TNF alpha levels
baseline, 3 months
Study Arms (2)
Nutritional intervention
SHAM COMPARATORThe subjects were undergoing nutritional intervention.
Nutritional intervention with green tea
EXPERIMENTALThe subjects were undergoing nutritional intervention complemented with green tea.
Interventions
The subjects were undergoing nutritional intervention was reduced by 500 kcal per day of habitual caloric intake. The proportion of daily intake of macronutrient in the moderate-fat diet was: 30% fat (saturated fat \<7%, monounsaturated 10-15% and polyunsaturated 10%, respectively to total calories), 15% of protein, and 55% of carbohydrates. The dietary cholesterol was less than 200 mg/day, fiber intake was increased to 25 grams per day (50% soluble fiber).
The patients drank secha green tea. Subjects of the INT group were instructed on how to prepare the green tea infusion. Each cup was prepared using 3g of dried green tea in 300ml of hot water (temperature 80°C)for 4 min. It was drunk fresh and without sugar. The treatment consisted of 2 cup/day of green tea, one in the morning and one at night. The amount of epigallocathechin-3-gallate was 498mg/day.
Eligibility Criteria
You may qualify if:
- obese women older than 18 years,
- in good health, as determined by a medical history questionnaire, and
- normal results of clinical laboratory tests excluding lipids
You may not qualify if:
- history of cardiovascular, hepatic, gastrointestinal, or renal disease;
- no alcoholism, no smoking, no exogenous hormone use or other medication;
- no supplemental vitamin or infusion drinking (tea, coffee); or
- treatment for weight loss 3 months before the start of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Guadalajara
Guadalajara, Jaliscco, 44280, Mexico
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
ERIKA MARTINEZ-LOPEZ, PhD
University of Guadalajara
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
May 17, 2012
First Posted
June 27, 2012
Study Start
April 1, 2007
Primary Completion
December 1, 2007
Study Completion
December 1, 2007
Last Updated
July 20, 2012
Record last verified: 2012-07